Small-Molecule Inhibitors of p53-MDM2 Interaction: the 2006-2010 Update

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|6|536-559

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.6, 2011-01, pp. : 536-559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patented small molecule inhibitors of p53–MDM2 interaction

By Deng Jinxia   Dayam Raveendra   Neamati Nouri  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 165-188

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of p53/MDM2 Interaction

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 159-165

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Protein-Protein Inhibitors for the p53-MDM2 Interaction

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-05 ,pp. : 952-960

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of the p53-MDM2

By  

Current Medicinal Chemistry, Vol. 15, Iss. 17, 2008-07 ,pp. : 1720-1730

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer

By Patel Sharmila   Player Mark R  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1865-1882

Informa Healthcare

Access to resources Recommend Favorite